Our 2021 sessions will focus on recent research in the field of venous and lymphatic disease, specifically around data from the AVLS PRO 2.0 Venous Registry.
In light of COVID-19, the AVLS 2021 Annual Congress will have virtual and in-person attendance options

 EDUCATIONAL OBJECTIVES

• Evaluate patients with venous and/or lymphatic disease and describe the interconnections of superficial venous, deep venous, and lymphatic disease.
• Assess the treatment goals that patients want to accomplish and the impact of venous and lymphatic disease on a patient's quality of life.
• Distinguish between the indications and contraindications of different treatment techniques and technologies.
• Diagnose and treat lymphedema and phlebolymphedema.
• Discuss advanced venous and lymphatic diseases and treatments, including wound care and ulcer management.

TARGETED AUDIENCE

The primary target audience of the 35th Annual Congress includes physicians, physician assistants, advanced registered nurse practitioners, ultrasound technologists, practice administrators, lymphedema therapists, and all other healthcare professionals currently or planning to care for patients with venous and lymphatic disease.

ACCREDITATION

The American Vein & Lymphatic Society (AVLS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Vein & Lymphatic Society (AVLS) designates this live activity for 21.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Vein & Lymphatic Society (AVLS) designates this internet enduring activity for 65.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.